The team at Dreamit takes a hands-on approach with each startup including weekly meetings with Managing Directors where startups hone their go-to-market strategyand pressure test ideas and critical assumptions.

Dreamit brings startups on a two-week customer immersion roadshow, expediting relationship building with at least 6-8 enterprise-level customers, including providers, health insurers, pharmas, and more.

Applications Close on February 10th 2017

Gartner Research's recent report on "Envisioning the IoT-Enabled R&D Digital Lab of the Future" explains how to:

• Articulate the value of "digital" in the laboratory
• Develop a "Laboratory of the Future"
• Implement a digital strategy across your organization

Former CAAP company QoC Health's CEO Raymond Shih shares a vision of connecting all aspects of health care.

Former OBIO CAAP Company, QoC Health, has been featured in the Canadian Medical Association Journal, Mobile Applications for Postoperative Monitoring after Discharge. The article was co-authored by Dr John Semple of QoC Health and Women's College Hospital.

WinterLight Labs, a Toronto-based company commercializing a speech-based platform for accurately detecting cognitive conditions such as dementia and Alzheimer’s Disease, recently closed the first tranche of $500,000 in seed funding from Novatio Ventures, an early stage life sciences investment firm.

OBIO Pre-CAAP, Akira, is planning to expand into 3 additional provinces: Quebec, Alberta, and BC. In addition to their existing coverage in Ontario, this will allow them to provide on-demand care to 90% of the Canadian population.

OBIO Pre-CAAP company, TranQool, has been featured on CP24 chatting about tips for dealing with Seasonal Affective Disorder (SAD).

OBIO Pre-CAAP, Akira, has partnered with Uberflip, a Toronto-based firm that builds content marketing platforms offering benefits specially tailored to Gen Yers.

Former OBIO CAAP company, Eve Medical, has been named as one of Reader's Digest Canadian Health Heroes and a need to know company.

OBIO CAAP Company, TECLA, features Switch Control and Platform Switching as an essential part of independence at home.

Pathcore won 1st Place at RESI Innovation Challenge in San Francisco!

An Executive Team from Taiwanese multinational, Wistron, will be visiting Canada with stops in Toronto, Ottawa and Montreal during the week of Feb 13, 2017 (Feb 13-14 in Toronto). Wistron is seeking partnerships including JVs, equity investments and distribution in sectors of medical technology, artificial intelligence, machine learning and Big Data.

You are invited to participate in this year’s biggest Ontario-China collaboration event in Toronto. Registration is free!

The Ministry of Research, Innovation and Science in partnership with the Consulate General of China in Toronto will host the 6th Ontario-China Research and Innovation Collaboration Forum (May 15) in conjunction with the 2017 OCE Discovery event to further strengthen collaboration under the Ontario-China MOU on Research and Innovation signed between the Government of Ontario and the Ministry of Science and Technology of China.

China is investing significantly in innovation to drive the economic growth. This provides golden opportunities for all of Ontario’s technology sectors. We look forward to your participation and engagement. 

The Honourable Minister Reza Moridi of the Ministry of Research, Innovation and Science and the Consul General from the Consulate General of China, have been invited to participate in the event and provide opening remarks at the Forum.

OBIO Pre-CAAP company Winterlight Labs has been featured in WIRED alongside cutting-edge tech for detecting autism and genetic disorders.

The Health Innovation Hub is Springboard’s program for women-led companies seeking growth funding and expert connections to develop solutions in pharma, including new drugs, diagnostics, pharma technologies, and drug-delivery devices.

TORONTO, CANADA -- (January 5, 2017) Exact Imaging (www.exactimaging.com), the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announced it has secured CDN $21.5 million in a Series C investment to commercialize its ExactVu™ micro-ultrasound system.